Among stakeholders in the biopharma value chain, there is a shared goal of improving the health of communities and operating responsibly. Several opportunities exist across this innovative ecosystem to deliver lasting sustainability impacts. For example, about 90% of greenhouse gas emissions come from indirect sources. How do we enable the right conversations with upstream and downstream players – suppliers, manufacturers, hospitals, and pharmacies – to better quantify that impact and work together to identify and enable solutions? This panel will discuss this and other opportunities to enhance sustainability through transformative collaboration across the biopharma ecosystem.